EnglishGermanChinese (Simplified)FrenchJapanese

Benefits of Detecting Brain Disease Early

So why early detect brain diseases when there is no cure yet? Knowing is power. Read on.

A Brief History

We’ve been officially fighting against brain diseases for ages. How long?

  • Lewy Body Dementia (LBD) was named in 1976,
  • Alzheimer’s in 1906
  • Parkinson’s was in 1817

That’s over 200 years (or eight generations if you’re into genealogy).

Of course, we’re not even counting the previous centuries when brain diseases namelessly devastated human lives.

So, have we been fighting hard?

Research efforts so far

Spending

In 2019, the National Institute of Health (NIH) spent:

  • $66 million on LBD research
  • $224 million on Parkinson’s research
  • $2.4 billion (yes, with a “B”) on Alzheimer’s research 

Clinical Trials

As of April 2021, there have been:

LBD

  • 131 clinical trials in various stages

Alzheimer’s 

  • 2,574 clinical trials in various stages

Parkinson’s

  • 2,891 clinical trials in various stages

Bottom Line:

What did we get for our three decades of hard work and $100 billion in brain disease drug development?

We still have no cure yet.

To turn the tide, we invented biomarker testing, a vital step in scientific innovation for personalized treatment.

What Makes Biomarker Testing a Game-Changer?

Knowing Empowers.  

It puts you in control to navigate your brain care journey and helps advance science for personalized medicine. 

why early testing

It puts you in control to navigate your brain care journey and helps advance science for personalized medicine. 

How our technology helps advance drug development for brain diseases.

Early Prevention Is Key.

According to the Alzheimer’s Association, by delaying the onset of Alzheimer’s just 5 years, the number of people affected plummets 42%.

Amprion - hero images - 66
amprion logo quote solid blue
Do good by doing well, do well by doing good.
Scroll to Top
Share on facebook
Share on twitter
Share on linkedin